Abstract
The presence of circulating tumor cells (CTCs) in patients with hepatocellular carcinoma (HCC) suggests metastasis to extra-hepatic organs. Snail is a key regulator of epithelial mesenchymal transition, which is closely associated with tumor metastasis. The aim of this study was to investigate the presence of CTCs and evaluate the significance of Snail mRNA levels in peripheral blood of HCC patients with and without extra-hepatic metastasis. Sixty-six consecutive patients with HCC (30 without metastasis, 36 with metastasis) were prospectively enrolled, as were 30 with liver cirrhosis and 23 healthy subjects. CTCs were isolated by FACS using Ber-EP4 and anti-CD45 antibodies, and CTC identity confirmed by immunofluorescent cytokeratin staining. Snail mRNA levels were measured by quantitative real-time PCR of blood samples. CTCs, positive for pan-cytokeratin and Snail, were isolated from five HCC patients with metastasis. The mean amount of Snail mRNA in HCC with metastasis was 18.8-fold, 26.6-fold greater than HCC without metastasis, liver cirrhosis, respectively. When compared with healthy controls, the mean level of Snail mRNA in HCC without metastasis was 10.1-fold greater (P < 0.001). In six patients showing complete remission of HCC, Snail mRNA decreased to levels similar to those of healthy controls. This study suggests the possibility that circulating Snail mRNA levels may have been associated with extra-hepatic metastasis in HCC patients.
Similar content being viewed by others
Abbreviations
- HCC:
-
Hepatocellular carcinoma
- CTC:
-
Circulating tumor cell
- EMT:
-
Epithelial mesenchymal transition
- AFP:
-
Alpha-fetoprotein
- FACS:
-
Fluorescence activated cell sorter
- PBMC:
-
Peripheral blood mononuclear cell
- RT-PCR:
-
Reverse-transcription polymerase chain reaction
- qRT-PCR:
-
Quantitative real-time PCR
References
Mazzaferro V, Regalia E, Doci R et al (1996) Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 334:693–699. doi:10.1056/NEJM199603143341104
Livraghi T, Goldberg SN, Lazzaroni S et al (1999) Small hepatocellular carcinoma: treatment with radio-frequency ablation versus ethanol injection. Radiology 210:655–661
Lencioni RA, Allgaier HP, Cioni D et al (2003) Small hepatocellular carcinoma in cirrhosis: randomized comparison of radio-frequency thermal ablation versus percutaneous ethanol injection. Radiology 228:235–240. doi:10.1148/radiol.2281020718
Takenaka K, Kawahara N, Yamamoto K et al (1996) Results of 280 liver resections for hepatocellular carcinoma. Arch Surg 131:71–76
Tung-Ping Poon R, Fan ST, Wong J (2000) Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma. Ann Surg 232:10–24. doi:10.1097/00000658-200007000-00003
Lise M, Bacchetti S, Da Pian P et al (1998) Prognostic factors affecting long term outcome after liver resection for hepatocellular carcinoma: results in a series of 100 Italian patients. Cancer 82:1028–1036. doi:10.1002/(SICI)1097-0142(19980315)82:6≤1028::AID-CNCR4≥3.0.CO;2-A
Kosuge T, Makuuchi M, Takayama T et al (1993) Long-term results after resection of hepatocellular carcinoma: experience of 480 cases. Hepatogastroenterology 40:328–332
Vauthey JN, Klimstra D, Franceschi D et al (1995) Factors affecting long-term outcome after hepatic resection for hepatocellular carcinoma. Am J Surg 169:28–34 (discussion-5)
Mazziotti A, Grazi GL, Cavallari A (1998) Surgical treatment of hepatocellular carcinoma on cirrhosis: a Western experience. Hepatogastroenterology 45(Suppl 3):1281–1287
Nagasue N, Uchida M, Makino Y et al (1993) Incidence and factors associated with intrahepatic recurrence following resection of hepatocellular carcinoma. Gastroenterology 105:488–494
Balsells J, Charco R, Lazaro JL et al (1996) Resection of hepatocellular carcinoma in patients with cirrhosis. Br J Surg 83:758–761. doi:10.1002/bjs.1800830610
Yamamoto J, Kosuge T, Takayama T et al (1996) Recurrence of hepatocellular carcinoma after surgery. Br J Surg 83:1219–1222. doi:10.1002/bjs.1800830913
Jwo SC, Chiu JH, Chau GY et al (1992) Risk factors linked to tumor recurrence of human hepatocellular carcinoma after hepatic resection. Hepatology 16:1367–1371
Nagao T, Inoue S, Goto S et al (1987) Hepatic resection for hepatocellular carcinoma. Clinical features and long-term prognosis. Ann Surg 205:33–40. doi:10.1097/00000658-198701000-00006
Di Carlo V, Ferrari G, Castoldi R et al (1995) Surgical treatment and prognostic variables of hepatocellular carcinoma in 122 cirrhotics. Hepatogastroenterology 42:222–229
Belghiti J, Panis Y, Farges O et al (1991) Intrahepatic recurrence after resection of hepatocellular carcinoma complicating cirrhosis. Ann Surg 214:114–117. doi:10.1097/00000658-199108000-00004
Chen MF, Hwang TL, Jeng LB et al (1994) Postoperative recurrence of hepatocellular carcinoma. Two hundred five consecutive patients who underwent hepatic resection in 15 years. Arch Surg 129(73):8–742
Shimada M, Takenaka K, Gion T et al (1996) Prognosis of recurrent hepatocellular carcinoma: a 10-year surgical experience in Japan. Gastroenterology 111:720–726. doi:10.1053/gast.1996.v111.pm8780578
Sakamoto Y, Kubota K, Mori M et al (1999) Surgical management for adrenal gland metastasis of hepatocellular carcinoma. Hepatogastroenterology 46:1036–1041
Inagaki Y, Unoura M, Urabe T et al (1993) Distant metastasis of hepatocellular carcinoma after successful treatment of the primary lesion. Hepatogastroenterology 40:316–319
Cristofanilli M, Hayes DF, Budd GT et al (2005) Circulating tumor cells: a novel prognostic factor for newly diagnosed metastatic breast cancer. J Clin Oncol 23:1420–1430. doi:10.1200/JCO.2005.08.140
Butler TP, Gullino PM (1975) Quantitation of cell shedding into efferent blood of mammary adenocarcinoma. Cancer Res 35:512–516
Ramaswamy S, Ross KN, Lander ES et al (2003) A molecular signature of metastasis in primary solid tumors. Nat Genet 33:49–54. doi:10.1038/ng1060
Pantel K, Alix-Panabieres C (2007) The clinical significance of circulating tumor cells. Nat Clin Pract 4:62–63
Paterlini-Brechot P, Benali NL (2007) Circulating tumor cells (CTC) detection: clinical impact and future directions. Cancer Lett 253:180–204. doi:10.1016/j.canlet.2006.12.014
Pantel K, Brakenhoff RH, Brandt B (2008) Detection, clinical relevance and specific biological properties of disseminating tumour cells. Nat Rev 8:329–340
Miyoshi A, Kitajima Y, Kido S et al (2005) Snail accelerates cancer invasion by upregulating MMP expression and is associated with poor prognosis of hepatocellular carcinoma. Br J Cancer 92:252–258
Lee TK, Poon RT, Yuen AP et al (2006) Twist overexpression correlates with hepatocellular carcinoma metastasis through induction of epithelial-mesenchymal transition. Clin Cancer Res 12:5369–5376. doi:10.1158/1078-0432.CCR-05-2722
Koesters R, von Knebel Doeberitz M (2003) The Wnt signaling pathway in solid childhood tumors. Cancer Lett 198:123–138. doi:10.1016/S0304-3835(03)00367-7
Monga SP, Monga HK, Tan X et al (2003) Beta-catenin antisense studies in embryonic liver cultures: role in proliferation, apoptosis, and lineage specification. Gastroenterology 124:202–216. doi:10.1053/gast.2003.50000
Cano A, Perez-Moreno MA, Rodrigo I et al (2000) The transcription factor Snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression. Nat Cell Biol 2:76–83. doi:10.1038/35000025
Olmeda D, Jorda M, Peinado H et al (2007) Snail silencing effectively suppresses tumour growth and invasiveness. Oncogene 26:1862–1874. doi:10.1038/sj.onc.1209997
Sugimachi K, Tanaka S, Kameyama T et al (2003) Transcriptional repressor Snail and progression of human hepatocellular carcinoma. Clin Cancer Res 9:2657–2664
Giannelli G, Bergamini C, Fransvea E et al (2005) Laminin-5 with transforming growth factor-beta1 induces epithelial to mesenchymal transition in hepatocellular carcinoma. Gastroenterology 129:1375–1383. doi:10.1053/j.gastro.2005.09.055
Bruix J, Sherman M (2005) Management of hepatocellular carcinoma. Hepatology 42:1208–1236
Latza U, Niedobitek G, Schwarting R et al (1990) Ber-EP4: new monoclonal antibody which distinguishes epithelia from mesothelial. J Clin Pathol 43:213–219. doi:10.1136/jcp.43.3.213
Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method. Methods 25:402–408
Blanco MJ, Moreno-Bueno G, Sarrio D et al (2002) Correlation of Snail expression with histological grade and lymph node status in breast carcinomas. Oncogene 21:3241–3246. doi:10.1038/sj.onc.1205416
Beach S, Tang H, Park S et al (2008) Snail is a repressor of RKIP transcription in metastatic prostate cancer cells. Oncogene 27:2243–2248. doi:10.1038/sj.onc.1210860
Roy HK, Smyrk TC, Koetsier J et al (2005) The transcriptional repressor SNAIL is overexpressed in human colon cancer. Dig Dis Sci 50:42–46. doi:10.1007/s10620-005-1275-z
Yang MH, Chang SY, Chiou SH et al (2007) Overexpression of NBS1 induces epithelial-mesenchymal transition and co-expression of NBS1 and Snail predicts metastasis of head and neck cancer. Oncogene 26:1459–1467. doi:10.1038/sj.onc.1209929
Becker KF, Rosivatz E, Blechschmidt K et al (2007) Analysis of the E-cadherin repressor Snail in primary human cancers. Cells Tissues Organs 185:204–212. doi:10.1159/000101321
Zha YH, He JF, Mei YW et al (2007) Zinc-finger transcription factor Snail accelerates survival, migration and expression of matrix metalloproteinase-2 in human bone mesenchymal stem cells. Cell Biol Int 31:1089–1096. doi:10.1016/j.cellbi.2007.03.023
Thiery JP, Sleeman JP (2006) Complex networks orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell Biol 7:131–142. doi:10.1038/nrm1835
Hermann PC, Huber SL, Herrler T et al (2007) Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell 1:313–323. doi:10.1016/j.stem.2007.06.002
Cristofanilli M, Budd GT, Ellis MJ et al (2004) Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N Engl J Med 351:781–791. doi:10.1056/NEJMoa040766
Budd GT, Cristofanilli M, Ellis MJ et al (2006) Circulating tumor cells versus imaging–predicting overall survival in metastatic breast cancer. Clin Cancer Res 12:6403–6409. doi:10.1158/1078-0432.CCR-05-1769
Nole F, Munzone E, Zorzino L et al (2008) Variation of circulating tumor cell levels during treatment of metastatic breast cancer: prognostic and therapeutic implications. Ann Oncol 19:891–897. doi:10.1093/annonc/mdm558
Acknowledgments
This study was supported in part by grant of the Leading Foreign Research Institute Recruitment Program and from FG06-12-01 of the 21C Frontier Functional Human Genome Project from the Ministry of Science & Technology in Korea.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Min, A.L., Choi, J.Y., Woo, H.Y. et al. High expression of Snail mRNA in blood from hepatocellular carcinoma patients with extra-hepatic metastasis. Clin Exp Metastasis 26, 759–767 (2009). https://doi.org/10.1007/s10585-009-9275-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10585-009-9275-6